Command Palette

Search for a command to run...

Clinical Trials · NCT04897802

Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

CompletedPhase 4Exenatide (Approved)
Phase
Phase 4
Recruitment status
Completed
Sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Enrollment
42
Start date
Sep 2021
Locations
1 site, Spain
Primary endpoint
Change in oxytocin concentration (pg/mL)
View Exenatide compound reference